Sample (aliquots) | Signal | Dose recovery ratio1 | Residuals1 (Gy) | CAM2 uncorrected De (Gy) | OD2 (%) | Fading4 g2days (%/decade) | CAM fading-corrected age (ka) |
---|---|---|---|---|---|---|---|
MS-01 (6) | IR50 | 0.93 ± 0.02 | 0.8 | 12.8 ± 1.0 | 6.6 | 2.5 ± 0.3 | 3.5 ± 0.4 |
pIR225 | 1.10 ± 0.02 | 4.9 | 32.9 ± 0.8 | 4.4 | 0.7 ± 0.3 | 7.1 ± 0.5 | |
MS-02 (7) | IR50 | 0.93 ± 0.05 | 0.6 | 17.9 ± 0.3 | 0.1 | 2.4 ± 0.3 | 5.0 ± 0.3 |
pIR225 | 0.99 ± 0.01 | 3.6 | 40.7 ± 1.2 | 7.3 | 0.6 ± 0.3 | 9.2 ± 0.7 | |
MS-03 (8) | IR50 | 1.07 ± 0.2 | 0.9 | 43.7 ± 0.9 | 4.5 | 2.6 ± 0.2 | 12.3 ± 0.8 |
pIR225 | 1.19 ± 0.04 | 8.0 | 69.4 ± 2.2 | 7.9 | 0.8 ± 0.2 | 15.1 ± 1.0 | |
MS-04 (8) | IR50 | 0.95 ± 0.02 | 0.9 | 39.3 ± 0.7 | 3.3 | 2.5 ± 0.2 | 10.9 ± 0.7 |
pIR225 | 1.03 ± 0.01 | 5.1 | 58.0 ± 1.4 | 5.2 | 0.8 ± 0.2 | 13.0 ± 0.8 | |
MS-05 (7) | IR50 | 0.94 ± 0.01 | 0.8 | 18.6 ± 0.6 | 6.9 | 2.1 ± 0.3 | 4.9 ± 0.4 |
pIR225 | 1.12 ± 0.02 | 5.3 | 36.5 ± 1.2 | 7.3 | 0.8 ± 0.3 | 7.7 ± 0.6 |